health pharma news today obesity drugs glp-1 today Data Brief: Prescriptions for Weight Loss over Time, 2018-2023 Alarming rise in weight loss
Description
Safety & Tolerability Side Effects and How to Manage Them Most side effects are gastrointestinal, mild to moderate in severity, and resolve within 4-8 weeks of continued use
In addition, obesity is also a significant health burden among Brazilians
GLP-1 medications like semaglutide and tirzepatide work by mimicking the incretin hormone GLP-1, which signals your brain to reduce appetite and tells your stomach to slow down
The test measures blood sugar levels, thyroid and kidney function among other components
